Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.
about
Construction and validation of a Bovine Innate Immune Microarray.Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytesCD4+ T-cell dynamics and host predisposition to infection.Influence of activating stimulus on functional phenotype: interleukin 2 mRNA accumulation differentially induced by ionophore and receptor ligands in subsets of murine T cells.The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta.Superinduction of the human gene encoding immune interferon.Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets.Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells.Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.Control of lymphokine expression in T helper 2 cells.Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3' untranslated region of bovine interleukin 2 cDNA.Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism.Inducible interleukin-1 gene expression in human vascular smooth muscle cells.T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expressionHelper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNAA labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell lineInvolvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replicationNfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells.Sequential expression of genes involved in human T lymphocyte growth and differentiation.Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin AProduction of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cellsRapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency.Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae.Stabilization of tubulin mRNA by inhibition of protein synthesis in sea urchin embryos.Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblastsRegulation of human histone gene expression during the HeLa cell cycle requires protein synthesis.Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytesAn overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.Cytokine gene expression in normal human lymphocytes in response to stimulation.2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA.Superinduction of the human interferon-beta promoter.Calpain expression in lymphoid cells. Increased mRNA and protein levels after cell activation.Induction of immunoglobulin gene expression in mouse fibroblasts by cycloheximide treatment.Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells.A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli.Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism
P2860
Q24814368-D6A767B2-3C39-4A1B-82F0-38E54DE6FD08Q28609877-4CCFFE27-F08F-4B49-9B4D-9400E393FEC9Q33620913-B666A83E-B1B9-4430-9AE9-310AED9AFB76Q33645208-C4D0A7CA-63BE-40F4-8856-957827354F08Q33832658-903C2FBE-395B-42EC-B887-19C789F25B86Q33928869-6967DAE9-D516-46EF-B8FA-47A5F05BCBFCQ33929024-45C3116B-DCF6-4D27-9B66-8DCAB13266C1Q34176755-DFA95BBA-23F4-4956-914D-E6454089526BQ34189072-9B288234-EFCD-4D21-AB81-7421B54FCC89Q34323615-651729C9-94D0-44DA-8C45-A0F4BD4968BEQ34346833-602DAD84-B817-492C-BB1D-4A372880F725Q34373148-279BCAA4-ADE5-484B-A9E7-889646711E76Q34548807-0A45F9D6-ADB7-46DB-9ECD-EAE7AFBA2CF1Q34553481-67203C43-3D9B-4922-9E71-D88A908CC858Q34574100-F0E84C69-683C-4E3F-B8C4-57DC3166DDA9Q34575360-46DBDB1F-E60C-4AA0-9D28-A8296FC6FB63Q35585717-1BE8C065-CB53-4286-9655-BED56E8E5A56Q35590350-F17FD8BC-3A92-4DFE-B235-9168D7AFC024Q35853996-603547FB-ED9C-4BDB-A088-DE0B00884569Q36350121-8C92A605-27E8-4D3F-9942-2014CAA66566Q36351738-492BBA02-2E54-47E0-8DE4-BFC9823ACA86Q36355648-61744975-E73C-4AF3-987F-9C8F0640D1B5Q36694541-7981D2E1-267F-4B8E-8B31-E8DBC674E664Q36708856-381CF51E-4471-462D-9A1F-6AB9B7AFCE11Q36793888-27921DB4-E80F-4555-827B-3C81CB205E4CQ36805114-A7CD377B-BB02-425A-AEA1-4C3545497DB5Q36895792-DED306AC-C827-4A31-BAA8-7813A476406CQ36916186-0970FC5D-7B8F-4C77-8492-BBA6843FEF0EQ36955456-C3F6BA60-48D4-4500-B7C6-DB2402A756C8Q37528225-E83D4A18-D2F2-45D6-842E-F09B00377327Q39464471-8F0A916A-1E71-4A85-922D-A4EFC6A40AF6Q39552152-B1161DD6-1FF5-46C8-B4DE-5BD3E364FDF7Q40018974-58E23258-9519-4453-BFB3-00F1A770B26AQ41334968-2EE3F5AF-3B3E-4993-B9CE-C1CB8BD24959Q41370362-CC42FC82-E795-4750-975A-09E961450613Q42937235-C389764B-7410-4D9E-A3FB-C886D17ADB8CQ44093961-4AD7AEAE-A98D-4ADB-9522-C232BB725D53Q48623563-3DF857CB-9638-41F7-8F32-F802C8FC57E6Q56766391-FC2ED0A3-57E0-4EDC-9F14-4B156B074CD2
P2860
Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Control of biologically active ...... in induced human lymphocytes.
@ast
Control of biologically active ...... in induced human lymphocytes.
@en
type
label
Control of biologically active ...... in induced human lymphocytes.
@ast
Control of biologically active ...... in induced human lymphocytes.
@en
prefLabel
Control of biologically active ...... in induced human lymphocytes.
@ast
Control of biologically active ...... in induced human lymphocytes.
@en
P2860
P356
P1476
Control of biologically active ...... n in induced human lymphocytes
@en
P2093
R Kaempfer
P2860
P304
P356
10.1073/PNAS.81.9.2601
P407
P50
P577
1984-05-01T00:00:00Z